Search Login Register

onapristone Summary

37 relevant articles (2 outcomes, 8 trials/studies) found for this Bio-Agent

Description: induces vaginal bleeding and luteal regression in monkeys; structure given in first source; progesterone antagonist

Also Known As: 11 beta-(4-dimethylaminophenyl)-17 alpha-hydroxy-17 beta-(3-hydroxypropyl)-13 alpha-methyl-4,9-gonadien-3-one; ZK 299; ZK 98.299; ZK 98299; ZK-299 Show All >>

Key Diseases for which onapristone is Relevant

  1. Premature Obstetric Labor (Premature Labor) : 1 outcome 2 studies in 5 results
  2. Endometriosis (Adenomyosis) : 1 outcome in 1 result
  3. Neoplasms (Cancer) : 3 studies in 11 results
  4. Meningioma (Meningiomas) : 1 study in 2 results
  5. Hemorrhage : 1 study in 2 results
Show All >>

Drugs Related to onapristone

  1. NG-Nitroarginine Methyl Ester (L-NAME)
  2. Nitric Oxide (Nitrogen Monoxide)
  3. Mifepristone (RU 486)
  4. Hormones
  5. Progesterone
  6. 9,10-Dimethyl-1,2-benzanthracene (DMBA)
  7. Estrogens (Estrogen)
  8. Tamoxifen
  9. Estrogen Receptor Modulators (Antiestrogen)
  10. Cyproterone Acetate
Show All >>

Therapies Related to onapristone

  1. Ovariectomy (Oophorectomy)
  2. Orchiectomy (Orchidectomy)
  3. Electrodes (Electrode)
  4. Heterologous Transplantation (Xenotransplantation)
  5. Aftercare (After-Treatment)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.